Development of 1 Month Sustained-Release Microspheres Containing Liraglutide for Type 2 Diabetes Treatment

Liraglutide has been extensively applied in the treatment of type 2 diabetes mellitus (T2DM), but its 11–15 h half-life resulted in daily administration, which led to poor patient compliance. This study aimed to solve this problem by developing liraglutide-loaded microspheres with a 1 month sustaine...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:ACS applied materials & interfaces 2024-05, Vol.16 (20), p.25869-25878
Hauptverfasser: Gao, Zejing, Wei, Yi, Ge, Jia, Liu, Jingxuan, Qin, Ying, Gong, Fangling, Ma, Guanghui
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!